Lack of Clinically Relevant Drug–Drug Interaction Between Empagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, and Verapamil, Ramipril, or Digoxin in Healthy Volunteers
Macha, Sreeraj, PhD, Sennewald, Regina, MD, Rose, Peter, MD, Schoene, Katja, Dipl-Math, Pinnetti, Sabine, MD, Woerle, Hans J., MD, Broedl, Uli C., MD
Published in Clinical therapeutics (01.03.2013)
Published in Clinical therapeutics (01.03.2013)
Get full text
Journal Article
A Randomized, Open-Label, Crossover Study to Evaluate the Pharmacokinetics of Empagliflozin and Linagliptin After Coadministration in Healthy Male Volunteers : Diabetes Update in Clinical Therapeutics
FRIEDRICH, Christian, METZMANN, Katrin, ROSE, Peter, MATTHEUS, Michaela, PINNETTI, Sabine, WOERLE, HansJ
Published in Clinical therapeutics (2013)
Get full text
Published in Clinical therapeutics (2013)
Journal Article